409 related articles for article (PubMed ID: 26524432)
1. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
[TBL] [Abstract][Full Text] [Related]
2. Immune pathomechanism of drug hypersensitivity reactions.
Pichler WJ; Naisbitt DJ; Park BK
J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S74-81. PubMed ID: 21354503
[TBL] [Abstract][Full Text] [Related]
3. Delayed drug hypersensitivity reactions - new concepts.
Posadas SJ; Pichler WJ
Clin Exp Allergy; 2007 Jul; 37(7):989-99. PubMed ID: 17581192
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of drug allergy--current concepts and recent insights.
Schnyder B; Brockow K
Clin Exp Allergy; 2015 Sep; 45(9):1376-83. PubMed ID: 26172398
[TBL] [Abstract][Full Text] [Related]
5. Drug hypersensitivity reactions involving skin.
Hausmann O; Schnyder B; Pichler WJ
Handb Exp Pharmacol; 2010; (196):29-55. PubMed ID: 20020258
[TBL] [Abstract][Full Text] [Related]
6. Delayed drug hypersensitivity: models of T-cell stimulation.
Adam J; Pichler WJ; Yerly D
Br J Clin Pharmacol; 2011 May; 71(5):701-7. PubMed ID: 21480949
[TBL] [Abstract][Full Text] [Related]
7. Drug hypersensitivity reactions: pathomechanism and clinical symptoms.
Pichler WJ; Adam J; Daubner B; Gentinetta T; Keller M; Yerly D
Med Clin North Am; 2010 Jul; 94(4):645-64, xv. PubMed ID: 20609855
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms leading to T-cell activation in drug hypersensitivity.
Meng X; Yerly D; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):317-324. PubMed ID: 29905574
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interaction of drugs with immune receptors: the p-i concept.
Pichler WJ; Beeler A; Keller M; Lerch M; Posadas S; Schmid D; Spanou Z; Zawodniak A; Gerber B
Allergol Int; 2006 Mar; 55(1):17-25. PubMed ID: 17075282
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.
Yun J; Adam J; Yerly D; Pichler WJ
Allergy; 2012 Nov; 67(11):1338-46. PubMed ID: 22943588
[TBL] [Abstract][Full Text] [Related]
11. Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions.
Illing PT; Mifsud NA; Purcell AW
Curr Opin Immunol; 2016 Oct; 42():31-40. PubMed ID: 27261882
[TBL] [Abstract][Full Text] [Related]
12. The structural basis of HLA-associated drug hypersensitivity syndromes.
Pompeu YA; Stewart JD; Mallal S; Phillips E; Peters B; Ostrov DA
Immunol Rev; 2012 Nov; 250(1):158-66. PubMed ID: 23046128
[TBL] [Abstract][Full Text] [Related]
13. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
[TBL] [Abstract][Full Text] [Related]
14. T cell-mediated hypersensitivity reactions to drugs.
Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
[TBL] [Abstract][Full Text] [Related]
15. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
Schmid DA; Depta JP; Lüthi M; Pichler WJ
Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162
[TBL] [Abstract][Full Text] [Related]
16. Predicting drug hypersensitivity by in vitro tests.
Pichler WJ
ALTEX; 2007; 24 Spec No():49-52. PubMed ID: 19835057
[TBL] [Abstract][Full Text] [Related]
17. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.
Yun J; Marcaida MJ; Eriksson KK; Jamin H; Fontana S; Pichler WJ; Yerly D
J Immunol; 2014 Apr; 192(7):2984-93. PubMed ID: 24591375
[TBL] [Abstract][Full Text] [Related]
18. NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS.
Phillips EJ
Trans Am Clin Climatol Assoc; 2018; 129():74-87. PubMed ID: 30166701
[TBL] [Abstract][Full Text] [Related]
19. Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions.
Sullivan A; Watkinson J; Waddington J; Park BK; Naisbitt DJ
Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):261-274. PubMed ID: 29460640
[TBL] [Abstract][Full Text] [Related]
20. Immune pathomechanism and classification of drug hypersensitivity.
Pichler WJ
Allergy; 2019 Aug; 74(8):1457-1471. PubMed ID: 30843233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
